Vibrown 0.9% Physiological Saline Injection (Sodium Chloride)

Adult administration

As sodium chloride, typically 20-1,000 mL is administered subcutaneously, intravenously, by intravenous drip, or rectally. The dosage and administration rate should be adjusted as appropriate based on age, weight, and symptoms.

This medication is an ampoule injection; care is needed when opening the glass container as glass fragments may mix in. Particular caution should be exercised when used in children and the elderly. This medication should not be administered to patients with hypernatremia, fluid overload, or edema and ascites due to liver cirrhosis. Caution is required when used in patients with heart or circulatory issues, impaired kidney function, hypoalbuminemia, and those with electrolyte abnormalities. Additionally, caution is necessary for patients with peripheral edema, pulmonary edema, preeclampsia, aldosteronism, or those taking specific medications. Side effects such as heart failure, edema, acidosis, and electrolyte abnormalities may occur with high-volume or rapid administration. Local side effects such as injection site infections, pain, thrombosis, and phlebitis may also occur, so careful observation is necessary. If any adverse reactions occur, administration should be stopped immediately, the patient's condition should be evaluated, and appropriate treatment should be provided. During the use of this medication, fluid balance, electrolyte levels, and acid-base status should be regularly monitored. Special caution is required for pregnant women, nursing mothers, women of childbearing age, newborns, infants, children, and the elderly; especially in the elderly, the administration speed should be slower and the dose adjusted. This medication's container is made of PVC material containing DEHP, but the risks due to DEHP are outweighed by the risks of not using the medication, so there is no need to avoid use. Before administration, check for any color change, precipitates, or crystals in the solution, and thoroughly disinfect the injection site and equipment. In cold weather, warm the medication to body temperature before use, and use any remaining medication immediately after opening or mixing with other medications, discarding any leftovers. Administration should be done slowly to minimize the occurrence of side effects.

Serious side effects

• Congestive heart failure
• edema
• serum electrolyte abnormalities

Mild side effects

• Fever
• injection site infections
• local pain or reaction
• venous irritation
• extravasation
• fluid overload

This medication should be stored in a sealed container to prevent air or moisture from entering. It is advisable to maintain storage temperature at room temperature, avoiding extremes of heat or cold.

Appearance

A colorless infusion preparation filled in a polyethylene container

Package unit

100 milliliters/bottle, 500 milliliters/bottle, 1000 milliliters/bottle